Medical Science

  • Home

Volume 27, Issue 138, August 2023

Extrapyramidal syndrome - anaesthetist’s challenge: A case report

Jui Jadhav1♦, Shrilekh Mankhair2

1Assistant Professor, Department of Anaesthesiology, Datta Meghe Institute of Higher Education and Research, Sawangi, Wardha, Maharashtra, India
2Senior Resident, Department of Anaesthesiology, Datta Meghe Institute of Higher Education and Research, Sawangi, Wardha, Maharashtra, India

♦Corresponding author
Assistant Professor, Department of Anaesthesiology, Datta Meghe Institute of Higher Education and Research, Sawangi, Wardha, Maharashtra, India

ABSTRACT

Extrapyramidal syndrome (EPS) is the condition commonly referred to as drug induced movement disorders, due to the side effects of drugs which the patients experience from dopamine receptor antagonists. The symptoms of EPS are debilitating, which interfere with the social functioning and communication, motor tasks and activities of daily living. This ultimately is associated with poor quality of life which may result in multiple hospital visits. This case is of a 28 years old female patient who was the known case of EPS and epilepsy and was on medications of antipsychotic drug Olanzapine, dopamine receptor agonist levodopa (100mg) plus carbidopa (25mg) and anti-epileptic drug levetiracetam who presented with an abscess in left loin region for 5 days which was insidious in onset and then gradually increased in size. It was associated with pain. This case study discusses how the patient with EPS with decreased swallowing reflexes, poor nutritional status and condition requiring surgery poses challenges to the anaesthesiologists in the peri operative period.

Keywords: Extrapyramidal syndrome, dopamine receptor blocking agents, abscess, epilepsy, anaesthesiologist

Medical Science, 2023, 27, e325ms3142
PDF
DOI: https://doi.org/10.54905/disssi/v27i138/e325ms3142

Published: 03 August 2023

Creative Commons License

© The Author(s) 2023. Open Access. This article is licensed under a Creative Commons Attribution License 4.0 (CC BY 4.0).